These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 39026155)

  • 1. Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines.
    De la Cruz-López KG; Alvarado-Ortiz E; Valencia-González HA; Beltrán-Anaya FO; Zamora-Fuentes JM; Hidalgo-Miranda A; Ortiz-Sánchez E; Espinal-Enríquez J; García-Carrancá A
    BMC Cancer; 2024 Jul; 24(1):853. PubMed ID: 39026155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
    Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
    J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells.
    Chen W; Pan Y; Wang S; Liu Y; Chen G; Zhou L; Ni W; Wang A; Lu Y
    BMC Cancer; 2017 Jan; 17(1):34. PubMed ID: 28061838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.
    Shi WY; Xiao D; Wang L; Dong LH; Yan ZX; Shen ZX; Chen SJ; Chen Y; Zhao WL
    Cell Death Dis; 2012 Mar; 3(3):e275. PubMed ID: 22378068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of mTORC1 through ATF4-induced REDD1 and Sestrin2 expression by Metformin.
    Jang SK; Hong SE; Lee DH; Kim JY; Kim JY; Ye SK; Hong J; Park IC; Jin HO
    BMC Cancer; 2021 Jul; 21(1):803. PubMed ID: 34253170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAPTOR promotes colorectal cancer proliferation by inducing mTORC1 and upregulating ribosome assembly factor URB1.
    Wang T; Zhang WS; Wang ZX; Wu ZW; Du BB; Li LY; Chen YF; Yang XF; Hao XY; Guo TK
    Cancer Med; 2020 Feb; 9(4):1529-1543. PubMed ID: 31886628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
    Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
    Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways.
    Sun C; Yang X; Jin Z; Gao Z
    J Chemother; 2023 May; 35(3):259-269. PubMed ID: 35731713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPK regulation of Raptor and TSC2 mediate metformin effects on transcriptional control of anabolism and inflammation.
    Van Nostrand JL; Hellberg K; Luo EC; Van Nostrand EL; Dayn A; Yu J; Shokhirev MN; Dayn Y; Yeo GW; Shaw RJ
    Genes Dev; 2020 Oct; 34(19-20):1330-1344. PubMed ID: 32912901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin Modulates Cyclin D1 and P53 Expression to Inhibit Cell Proliferation and to Induce Apoptosis in Cervical Cancer Cell Lines.
    Yudhani RD; Astuti I; Mustofa M; Indarto D; Muthmainah M
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1667-1673. PubMed ID: 31244286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.
    Soares HP; Ni Y; Kisfalvi K; Sinnett-Smith J; Rozengurt E
    PLoS One; 2013; 8(2):e57289. PubMed ID: 23437362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
    Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
    Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
    Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
    PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/Gαi/mTORC1 axis.
    Dillenburg-Pilla P; Patel V; Mikelis CM; Zárate-Bladés CR; Doçi CL; Amornphimoltham P; Wang Z; Martin D; Leelahavanichkul K; Dorsam RT; Masedunskas A; Weigert R; Molinolo AA; Gutkind JS
    FASEB J; 2015 Mar; 29(3):1056-68. PubMed ID: 25466898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acidic tumor microenvironment abrogates the efficacy of mTORC1 inhibitors.
    Faes S; Duval AP; Planche A; Uldry E; Santoro T; Pythoud C; Stehle JC; Horlbeck J; Letovanec I; Riggi N; Demartines N; Dormond O
    Mol Cancer; 2016 Dec; 15(1):78. PubMed ID: 27919264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion.
    Kauffman EC; Lang M; Rais-Bahrami S; Gupta GN; Wei D; Yang Y; Sourbier C; Srinivasan R
    BMC Cancer; 2019 Sep; 19(1):917. PubMed ID: 31519159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression.
    Xia C; Liu C; He Z; Cai Y; Chen J
    J Exp Clin Cancer Res; 2020 Jul; 39(1):127. PubMed ID: 32631421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two parallel pathways connect glutamine metabolism and mTORC1 activity to regulate glutamoptosis.
    Bodineau C; Tomé M; Courtois S; Costa ASH; Sciacovelli M; Rousseau B; Richard E; Vacher P; Parejo-Pérez C; Bessede E; Varon C; Soubeyran P; Frezza C; Murdoch PDS; Villar VH; Durán RV
    Nat Commun; 2021 Aug; 12(1):4814. PubMed ID: 34376668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.